Insulet CorporationPODD recently announced the receipt of ISO (International Standards Organization) 27001 certification for its Omnipod DASH System. At the same time, the company also informed about ...

LONDON--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System ...

Insulet PODD appears well-positioned on solid prospects in the diabetes market. The company is progressing well with respect to product innovation and geographic expansion. The stock carries a Zacks ...

Insulet Corporation PODD announced the launch of the Omnipod DASH Insulin Management System (Omnipod DASH System) in Canada. Notably, the company plans to launch the Omnipod DASH System throughout ...

Insulet Corporation’s PODD Omnipod and Omnipod DASH insulin management systems recently received FDA’s approval for their use with Eli Lilly and Company’s LLY Lyumjev (insulin lispro-aabc injection) ...

BILLERICA, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), ...

The US Food and Drug Administration has cleared Insulet's Omnipod DASH Insulin Management System, a major revamp of the tubing-free insulin delivery device for use in diabetes. The Omnipod, first ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH® Personal Diabetes Managers (PDMs) distributed globally.

Insulet has begun a voluntary recall of the remote-control devices used with its Omnipod Dash insulin pumps after discovering that the devices’ batteries may be at risk of swelling, leaking or ...